Compare EOLS & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOLS | VMD |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.4M | 465.4M |
| IPO Year | 2018 | 2018 |
| Metric | EOLS | VMD |
|---|---|---|
| Price | $5.71 | $12.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 776.9K | 364.1K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.23 | ★ 32.14 |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $297,176,000.00 | $270,280,000.00 |
| Revenue This Year | $13.27 | $17.88 |
| Revenue Next Year | $17.62 | $14.98 |
| P/E Ratio | ★ N/A | $201.67 |
| Revenue Growth | 11.61 | ★ 20.52 |
| 52 Week Low | $3.86 | $5.93 |
| 52 Week High | $10.20 | $12.61 |
| Indicator | EOLS | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.66 | 66.50 |
| Support Level | $4.02 | $9.26 |
| Resistance Level | $7.16 | N/A |
| Average True Range (ATR) | 0.33 | 0.37 |
| MACD | -0.17 | -0.05 |
| Stochastic Oscillator | 11.95 | 63.70 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.